Popular weight loss drugs Ozempic and Wegovy have been linked to significant gastrointestinal problems in a handful of patients, according to new research published on Thursday in the Journal of the American Medical Association.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.